Smoking may have negative effect on breast cancer survival
the ONA take:
Premenopausal women with breast cancer are at increased risk of dying if they smoke, according to new research from Japanese investigators. This prospective study followed 848 women with breast cancer for a median of 6.7 years.
Study findings indicate that premenopausal women who smoked for more than 21.5 years had a 3.1 times higher risk of dying from any cause and a 3.4 times higher risk of dying from breast cancer.
In addition, the increased risk was especially relevant to women whose cancers expressed both the estrogen receptor and the progesterone receptor.
The authors hope their study will help in advising patients about how their smoking might affect their outcome, and encourage them to quit smoking.
Premenopausal women with breast cancer are at increased risk of dying if they smoke.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|